Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHammerson Regulatory News (HMSO)

Share Price Information for Hammerson (HMSO)

Share Price is delayed by 15 minutes
Get Live Data
326.20    -4.40 (-1.33%)
Bid:
326.00
Ask:
326.60
Spread: 0.60 (0.184%)
Market Cap: £1.73b
HMSO Live PriceLast checked at - London Stock Exchange

Intraday Hammerson Share Chart

Response to Press Speculation

3 Aug 2020 07:00

RNS Number : 8453U
Hammerson PLC
03 August 2020
 

3 August 2020

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EC NO. 596/2014) ("MAR")

 

Hammerson plc

 

Response to Press Speculation

 

 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, INTO OR WITHIN THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION

 

Hammerson plc (the 'Company') notes recent press speculation.

 

The Company confirms that it is in advanced discussions on the terms of a possible disposal of its 50% interest in VIA Outlets to its joint venture partner APG. It is also considering a possible equity raise by way of a rights issue.

 

The Company continues to take pro-active measures relating to the management of its cost base and cash-flow and in recent weeks it secured approval for the issuance of up to £300m under the Covid Corporate Finance Facility (CCFF) from the Bank of England. Following the reopening of its flagship destinations across Europe, footfall and sales continue to improve and Q3 rent collection in the UK (excluding monthly payments and deferrals) has increased to over 30%.

 

The Company will provide a further update in due course, if appropriate.

 

The announcement above has also been released on the SENS system of the Johannesburg Stock Exchange.

 

ENDS

 

This announcement is for information purposes only and shall not constitute or form part of any offer to issue or sell, or the solicitation of any offer to purchase, subscribe for or otherwise acquire, any securities of the Company in the United States (including its territories and possessions, any state of the United States and the District of Columbia) (the "United States" or "US") or any other jurisdiction. No public offering of the Securities is being made in any such jurisdiction. The securities referred to herein (the "Securities") have not been and will not be registered under the US Securities Act of 1933, as amended (the "Securities Act") or with any securities regulatory authority of any state or other jurisdiction of the United States, and accordingly may not be offered, sold, resold, pledged, taken up, exercised, renounced, delivered, distributed or transferred directly or indirectly, into or within the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with any applicable securities laws of any relevant state or other jurisdiction of the United States. No public offering of the Securities has been or will be made in the United States.

 

For further information:

 

Investor Contact

Josh Warren, Hammerson, Head of Investor Relations

Tel: +44 20 7887 1053

josh.warren@hammerson.com

 

Press Contacts

Hammerson

Catrin Sharp, Head of Corporate Communications

Tel: +44 20 7887 1063

catrin.sharp@hammerson.com

 

FTI Consulting (for Hammerson)

John Waples/ Dido Laurimore

Tel: +44 20 3727 1000/ 0780 1654424

dido.laurimore@fticonsulting.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RSPKKDBNOBKDAFK
Date   Source Headline
8th May 20257:00 amRNSTransaction in Own Shares
7th May 20254:30 pmRNSTotal Voting Rights
7th May 20257:00 amRNSTransaction in Own Shares
6th May 20257:00 amRNSTransaction in Own Shares
2nd May 20257:00 amRNSTransaction in Own Shares
1st May 20257:00 amRNSTransaction in Own Shares
30th Apr 202512:30 pmRNSTotal Voting Rights
30th Apr 20257:00 amRNSTransaction in Own Shares
29th Apr 20257:00 amRNSTransaction in Own Shares
28th Apr 20257:00 amRNSTransaction in Own Shares
25th Apr 20257:00 amRNSTransaction in Own Shares
24th Apr 20257:00 amRNSTransaction in Own Shares
23rd Apr 20257:00 amRNSTransaction in Own Shares
22nd Apr 20252:00 pmRNSTotal Voting Rights
22nd Apr 20257:00 amRNSTransaction in Own Shares
16th Apr 20257:00 amRNSTransaction in Own Shares
15th Apr 20254:40 pmRNSEMTN Programme: publication of Base Prospectus
15th Apr 20253:30 pmRNSTotal Voting Rights
15th Apr 20259:30 amRNSDividend Currency Conversion Announcement
15th Apr 20257:00 amRNSTransaction in Own Shares
14th Apr 20257:00 amRNSTransaction in Own Shares
11th Apr 20257:00 amRNSTransaction in Own Shares
10th Apr 20257:00 amRNSTransaction in Own Shares
9th Apr 20257:01 amRNSTotal Voting Rights
9th Apr 20257:00 amRNSTransaction in Own Shares
8th Apr 20253:30 pmRNSDirector/PDMR Shareholding
8th Apr 202512:30 pmRNSDirector/PDMR Shareholding
8th Apr 20257:00 amRNSTransaction in Own Shares
7th Apr 20257:00 amRNSTransaction in Own Shares
4th Apr 20257:00 amRNSTransaction in Own Shares
3rd Apr 20257:00 amRNSTransaction in Own Shares
2nd Apr 20257:00 amRNSTransaction in Own Shares
1st Apr 20253:00 pmRNSTotal Voting Rights
1st Apr 20257:00 amRNSTransaction in Own Shares
31st Mar 20252:30 pmRNSTotal Voting Rights
31st Mar 20257:00 amRNSTransaction in Own Shares
28th Mar 20251:30 pmRNSDirector Declaration
28th Mar 20257:00 amRNSTransaction in Own Shares
27th Mar 20251:00 pmRNSDirector/PDMR Shareholding
27th Mar 20257:00 amRNSTransaction in Own Shares
26th Mar 20257:00 amRNSTransaction in Own Shares
25th Mar 20253:45 pmRNSTotal Voting Rights
25th Mar 20253:00 pmRNSDirector/PDMR Shareholding
25th Mar 20257:00 amRNSTransaction in Own Shares
24th Mar 20257:00 amRNSTransaction in Own Shares
21st Mar 20257:00 amRNSTransaction in Own Shares
20th Mar 20257:00 amRNSTransaction in Own Shares
19th Mar 20257:00 amRNSTransaction in Own Shares
18th Mar 20253:15 pmRNSTotal Voting Rights
18th Mar 20253:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.